A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis

Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2017
Cargando información sobre las referencias
The primary purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) by assessing the reduction in signs and symptoms of PsA.
Epistemonikos ID: 382595cf11f8941f18b5277e6fc127bd63e94d6e
First added on: Feb 15, 2022